JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vargas, R.
Right arrow Articles by Cafruny, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vargas, R.
Right arrow Articles by Cafruny, E. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 135, Issue 1, 112-119, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF MERCURIAL COMPOUNDS ON RENAL PERFUSION PRESSURE

R. Vargas 1 and E. J. Cafruny 2

1 Dept. of Pharmacology, U. of Mexico, Mexico City, Mexico
2 Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan

Perfusion pressure in the renal vascular bed was determined in dogs after administration of various mercurial compounds. Diuretic mercurials and the nondiuretic mercurial, p-chloromercuribenzoate, produced a sustained increase in perfusion pressure which usually lasted for the duration of an experiment (up to 4 hours). An increase in urine flow accompanied the rise in perfusion pressure but urinary sodium concentration was depressed when the nondiuretic compound was employed and elevated when diuretic mercurials were used.

The increase in urine flow noted when perfusion pressure was raised by administration of a nondiuretic mercurial exceeded that produced when perfusion pressure was elevated artificially by increasing renal blood flow. This effect of the mercurial may be due to impairment of the renal concentrating mechanism.

Submitted on July 3, 1961







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.